UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Inquiry Search clinical trials

Name
UMIN ID

Recruitment status Completed
Unique ID issued by UMIN UMIN000024543
Receipt No. R000028250
Scientific Title Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection
Date of disclosure of the study information 2016/10/24
Last modified on 2016/10/25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection
Acronym Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection
Scientific Title Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection
Scientific Title:Acronym Effects of Preoperative Immunonutrition in Patients Undergoing major hepatobiliary resection
Region
Japan

Condition
Condition Bile Duct Cancer
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to determine whether preoperative immunonutrition is effective on infectious complication and Th1/Th2 differentiation in patients with major hepatobiliary resection.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Phase IV

Assessment
Primary outcomes postoperative infectious complication
Key secondary outcomes plasma IL-6, CRP, Th1/Th2 balance, resolvin E1

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine Food
Interventions/Control_1 Dietary Supplement: Oral IMPACT
oral supplement for 5 days(1L/day) before surgery of a formula enriched with arginine, omega-3 fatty acids, and RNA

Other Name: Oral IMPACT; Ajinomoto Pharma Co., Ltd, Tokyo, Japan
Interventions/Control_2 ordinary diet
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria hemihepatectomy with bile duct resection
Key exclusion criteria ongoing infection
gastrointestinal obstruction
respiratory dysfunction
cardiac dysfunction
hepatic dysfunction
renal failure
history of recent immunosuppressive or immunological disease
preoperative evidence of widespread metastatic disease
Target sample size 40

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Katsunori Furukawa
Organization Chiba University
Division name Department of General Surgery
Zip code
Address 1-8-1 inohana, chuo-ku, chiba city
TEL 043-222-7171
Email k-furukawa@umin.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Katsunori Furukawa
Organization Chiba University
Division name Department of General Surgery
Zip code
Address 1-8-1 inohana, chuo-ku, chiba city
TEL 043-222-7171
Homepage URL
Email k-furukawa@umin.ac.jp

Sponsor
Institute Chiba University
Department of General Surgery
Institute
Department

Funding Source
Organization Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs YES
Study ID_1 NCT01256047
Org. issuing International ID_1 ClinicalTrials.gov
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 10 Month 24 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications https://www.ncbi.nlm.nih.gov/pubmed/26965712
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2009 Year 02 Month 01 Day
Date of IRB
Anticipated trial start date
2009 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2016 Year 10 Month 24 Day
Last modified on
2016 Year 10 Month 25 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028250

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.